Samantha Viviana Bernadez Vallejo

Mrs. Samantha Viviana Bernadez Vallejo


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Lorenza DiazLorenza Diaz
Lorenza Diaz
Samantha Viviana Bernadez VallejoSamantha Viviana Bernadez Vallejo
Samantha Viviana Bernadez Vallejo
Rafael Vargas-CastroRafael Vargas-Castro
Rafael Vargas-Castro
EAEuclides Avila
Euclides Avila
KGKarla A. Gómez-Ceja
Karla A. Gómez-Ceja
JGJanice Garcia-Quiroz
Janice Garcia-Quiroz
Cervical cancer is the fourth most common cancer among women worldwide. The main factor associated with the onset and progression of this neoplasia is the human papillomavirus (HPV) infection. The HPV-oncogenes E6 and E7 are critical drivers of cellular transformation, promoting the expression of oncogenes such as KCNH1. The phytochemical α-mangostin (AM) is a potent antineoplastic and antiviral compound. However, its effects on HPV oncogenes and KCNH1 gene expression remain unknown. This study evaluated the effects of AM on cell proliferation, cell cycle distribution and gene expression, including its effects on tumor growth in xenografted mice. AM inhibited cell proliferation in a concentration-dependent manner, being the most sensitive cell lines those with the highest number of HPV16 copies. In addition, AM promoted G1-cell cycle arrest in CaSki cells, while led to cell death in SiHa and HeLa cells. Of interest was the finding of an AM-dependent decreased gene expression of E6, E7 and KCNH1 both in vitro and in vivo, as well as the modulation of cytokine expression, Ki-67, and tumor growth inhibition. On these bases, we suggest that AM represents a good option as an adjuvant for the treatment and prevention of cervical cancer.